FCCC LOGO Faculty Publications
Tempero MA , Malafa MP , Chiorean EG , Czito B , Scaife C , Narang AK , Fountzilas C , Wolpin BM , Al-Hawary M , Asbun H , Behrman SW , Benson AB , Binder E , Cardin DB , Cha C , Chung V , Dillhoff M , Dotan E , Ferrone CR , Fisher G , Hardacre J , Hawkins WG , Ko AH , LoConte N , Lowy AM , Moravek C , Nakakura EK , O'Reilly EM , Obando J , Reddy S , Thayer S , Wolff RA , Burns JL , Zuccarino-Catania G
Pancreatic Adenocarcinoma, Version 1.2019
J Natl Compr Canc Netw. 2019 Mar;17(3) :202-210
Back to previous list
Abstract
The NCCN Guidelines for Pancreatic Adenocarcinoma discuss the diagnosis and management of adenocarcinomas of the exocrine pancreas and are intended to assist with clinical decision-making. These NCCN Guidelines Insights discuss important updates to the 2019 version of the guidelines, focusing on postoperative adjuvant treatment of patients with pancreatic cancers.
Notes
Tempero, Margaret A. Malafa, Mokenge P. Chiorean, E. Gabriela Czito, Brian Scaife, Courtney Narang, Amol K. Fountzilas, Christos Wolpin, Brian M. Al-Hawary, Mahmoud Asbun, Horacio Behrman, Stephen W. Benson, Al B., III Binder, Ellen Cardin, Dana B. Cha, Charles Chung, Vincent Dillhoff, Mary Dotan, Efrat Ferrone, Cristina R. Fisher, George Hardacre, Jeffrey Hawkins, William G. Ko, Andrew H. LoConte, Noelle Lowy, Andrew M. Moravek, Cassadie Nakakura, Eric K. O'Reilly, Eileen M. Obando, Jorge Reddy, Sushanth Thayer, Sarah Wolff, Robert A. Burns, Jennifer L. Zuccarino-Catania, Griselda 1540-1413 J Natl Compr Canc Netw. 2019 Mar 1;17(3):202-210. doi: 10.6004/jnccn.2019.0014.